Cardiac Arrhythmia
122
18
23
62
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
17 trials with published results (14%)
Research Maturity
62 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.5%
3 terminated out of 122 trials
95.4%
+8.9% vs benchmark
2%
3 trials in Phase 3/4
27%
17 of 62 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 62 completed trials
Clinical Trials (122)
Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch
In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)
Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmias
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Virtual E-health System for Implantable Cardioverter Defibrillators
The Effects of Low-Flow and Normal-Flow Sevoflurane Anesthesia on Frontal QRS-T Angle and TP-e Interval
NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation
Mayo AVC Registry and Biobank
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias
Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest
Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias
Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)
Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm
Modified Left Atrial Maze Procedure for Concomitant AF Ablation
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
Spanish Registry of Redo Procedures Following Pulmonary Vein Ablation by Pulsed Field Ablation Technology: RESET-PFA
Evaluation of the BIOTRONIK AutoAdapt Algorithm for Continuous Automatic Adaptive Cardiac Resynchronization
Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)